Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Analysis of hospital admittance and mortality in AIDS patients].
Cervero M, Jusdado JJ, Torres R, Solís J. Cervero M, et al. Among authors: torres r. Enferm Infecc Microbiol Clin. 2004 Aug-Sep;22(7):436; author reply 436-8. doi: 10.1016/s0213-005x(04)73131-6. Enferm Infecc Microbiol Clin. 2004. PMID: 15355778 Spanish. No abstract available.
[Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression].
Cervero M, Torres R, Jusdado JJ, Rodríguez-Rosado R, Del Alamo M, García-Benaya E. Cervero M, et al. Among authors: torres r. Enferm Infecc Microbiol Clin. 2006 Aug-Sep;24(7):426-30. doi: 10.1157/13091779. Enferm Infecc Microbiol Clin. 2006. PMID: 16956530 Spanish.
Economic evaluation of assistance to HIV patients in a Spanish hospital.
Velasco M, Losa JE, Espinosa A, Sanz J, Gaspar G, Cervero M, Torres R, Condes E, Barros C, Castilla V. Velasco M, et al. Among authors: torres r. Eur J Intern Med. 2007 Sep;18(5):400-4. doi: 10.1016/j.ejim.2006.12.013. Epub 2007 Jul 13. Eur J Intern Med. 2007. PMID: 17693228
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Berenguer J, González J, Ribera E, Domingo P, Santos J, Miralles P, Angels Ribas M, Asensi V, Gimeno JL, Pérez-Molina JA, Terrón JA, Santamaría JM, Pedrol E; GESIDA 3903 Team. Berenguer J, et al. Clin Infect Dis. 2008 Oct 15;47(8):1083-92. doi: 10.1086/592114. Clin Infect Dis. 2008. PMID: 18781872 Clinical Trial.
2,009 results